We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

hsTnT After Elective Coronary Angiography

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01735500
Recruitment Status : Completed
First Posted : November 28, 2012
Last Update Posted : December 9, 2014
Information provided by (Responsible Party):

Study Description
Brief Summary:
A prospective Study, aiming to understand and analyse the key role of the novel High Sensitivity Troponin T (hsTnT) within a group of patients undergoing an uncomplicated coronary angiography without receiving any additional intervention. The peri-procedural elevation of the hsTnT indicates some other factors being responsible for the elevation of the hsTnT in absence of an acute coronary syndrome, such as physiological components or micro-injuries. A one year follow-up has been collected.

Condition or disease
Coronary Artery Disease

Study Design

Study Type : Observational
Actual Enrollment : 545 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Rise of hscTnT After Elective Coronary Angiography Without Coronary Intervention
Study Start Date : February 2010
Primary Completion Date : November 2011
Groups and Cohorts

CAG without PCI
CAG with PCI

Outcome Measures

Primary Outcome Measures :
  1. Cardiovascular mortality [ Time Frame: Up to 12 months after procedure ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Consecutive patients with stable or unknown CAD undergoing CAG with/or without PCI. Patients receiving additional examination, such as biopsy, Ablation or any other procedure that could lead to myocardial injury resulting in elevation of the cardiac Troponin are being excluded, as well as Patients with acute coronary syndrome.

Inclusion Criteria:

- Stable or unknown CAD

Exclusion Criteria:

- Acute Coronary Syndrome

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01735500

Department of Cardiology - University Hospital of Heidelberg
Heidelberg, Germany, 69120
Sponsors and Collaborators
University Hospital Heidelberg
Principal Investigator: Evangelos Giannitsis, Prof. Dr. med. Department of Cardiology, University Hospital of Heidelberg
More Information

Responsible Party: Haitham Abu Sharar, Dr. med., University Hospital Heidelberg
ClinicalTrials.gov Identifier: NCT01735500     History of Changes
Other Study ID Numbers: hsTnT Elective CAG
First Posted: November 28, 2012    Key Record Dates
Last Update Posted: December 9, 2014
Last Verified: December 2014

Keywords provided by Haitham Abu Sharar, University Hospital Heidelberg:
cardia Troponin T
in stable

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arterial Occlusive Diseases
Vascular Diseases